Addex Therapeutics (ADXN) EBITDA Margin (QoQ) (2019 - 2025)
Addex Therapeutics (ADXN) EBITDA Margin (QoQ) (2019 - 2025) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Addex Therapeutics | 534.71 Mn | 534.71 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -31.19 Mn |
| Dec 31, 2024 | -18.15 Mn |
| Sep 30, 2024 | -37,557.00 |
| Jun 30, 2024 | -44,259.00 |
| Mar 31, 2024 | 112,416.00 |
| Dec 31, 2023 | -123,309.00 |
| Sep 30, 2023 | -16,581.00 |
| Jun 30, 2023 | 1,060.00 |
| Mar 31, 2023 | 339,030.00 |
| Dec 31, 2022 | -244,592.00 |
| Sep 30, 2022 | 285,026.00 |
| Jun 30, 2022 | -143,900.00 |
| Mar 31, 2022 | -193,726.00 |
| Dec 31, 2021 | 3,253.00 |
| Sep 30, 2021 | -7,029.00 |
| Jun 30, 2021 | -8,114.00 |
| Mar 31, 2021 | -5,727.00 |
| Dec 31, 2020 | 1.11 Mn |
| Sep 30, 2020 | -1.11 Mn |
| Jun 30, 2020 | 12,719.00 |